Runa Capital
Runa Capital is a venture capital firm based in Luxembourg, Luxembourg, focused on Pre-Seed to Series A startups in Artificial Intelligence, SaaS & Enterprise, and Fintech. This profile covers its focus and how founders can get in front of it in 2026.
Runa Capital is a Luxembourg-based VC focusing on Deeptech, enterprise software and fintech infrastructure.
- Investment focus
- Artificial IntelligenceSaaS & EnterpriseFintechQuantum & SemiconductorsDeveloper Tools & DataHealthcare & Biotech
- Investment stages
- Pre-SeedSeedSeries A
- Location
- Luxembourg, Luxembourg
- Team size
- 11-50
- Portfolio companies
- 100+
- Latest deal on record
- May 2026
About Runa Capital
Runa Capital is a technology-focused venture capital firm managing two funds - Runa I was launched with $135M in 2010 and has made 33 investments, Runa II of $135M was launched in 2014 and has made 30 investmerns and Runa III was started in 2019 and is in active investment stage right now.
The fund was established to seek early stage opportunities in the rapidly growing tech sector, with the specific focus on deeptech (AI, ML, open-source), future of computing, fintech infrastructure and enterprise software. Runa brings a team with extensive operational experience and is focused on finding growth businesses that generate revenues, supporting them in the global marketplace and turning them into international champions.
Founded by Ilya Zubarev, Serg Bell (founders of Parallels and Acronis) and Dmitry Chikhachev (Ericsson, Ritzio, Uvenco) Runa Capital is run by a team of successful entrepreneurs, most of whom have worked together for over 15 years.
It is a united team with broad geographical and cross-industry experience, as well as an extensive professional network. Runa Capital investment team members possess an excellent track record in tech investments.
Source: the organization's public company profile.
How to pitch Runa Capital
The founders who hear back from Runa Capital lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Runa Capital
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Runa Capital." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/runa-capital
Frequently Asked Questions
What does Runa Capital invest in?
Runa Capital focuses on Artificial Intelligence, SaaS & Enterprise, Fintech, and Quantum & Semiconductors. Match your sector and stage before reaching out, then find similar active investors on Round Funded.
What stage does Runa Capital invest at?
Runa Capital focuses on Pre-Seed to Series A rounds. Lead with traction that fits the stage when you reach out.
Is Runa Capital actively investing?
Yes. Round Funded's research found that Runa Capital has made a new investment or run a new cohort since 2024, and its latest deal on record is from May 2026. Reach out with a personalized pitch that fits its stage and focus, then track who opens it.
Where is Runa Capital based?
Runa Capital is based in Luxembourg, Luxembourg. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Runa Capital?
Unlock a verified email for Runa Capital and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.